NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib
暂无分享,去创建一个
Christopher J. Miller | D. Elder | K. Nathanson | W. Xu | V. Parekh | Xiaowei Xu | J. Sobanko | L. Schuchter | R. Amaravadi | E. Chu | G. Karakousis | R. Elenitsas | R. Letrero | M. Wilson | C. Miller